期刊文献+

基于药物美金刚的专利技术分析

Proprietary Technology Analysis Based On Drug Memantine
在线阅读 下载PDF
导出
摘要 通过分析药物美金刚的专利申请现状,把握此类药物可能的发展方向,为国内相关企业提供系统完整的专利研究和分析,并根据国内专利现状制定相应的应对策略和长远发展规划,为阿尔茨海默病的治疗提供一定的帮助。从美金刚相关专利出发,对美金刚专利申请量趋势、专利申请人等进行了分析。预期未来的发展方向可能包括美金刚前体、晶型、药物联用、寻求新的高效制备方法等方面。企业可以加强技术合作和创新研发,努力推进治疗阿尔茨海默病的药物研究,不断开发外围专利技术,提高企业的市场竞争力,从而获得更大的市场份额和利润。 By analyzing state of patent application for drug memantine,ascertaining possible direction of development of this drug,providing systematic complete patent research and analysis for domestic related businesses,and developing corresponding coping strategies and long-term development programs based on state of patent,providing some assistance for treatment of Alzheimer's disease.Based on the patents related to Memantine,this paper analyzes the trend of patent application volume and patent applicants.The expected future development directions may include the precursor,crystal form,drug combination,and seeking new and efficient preparation methods of Memantine.Businesses can enhance technology collaboration and innovation development,strives to advance drug research for treatment of Alzheimer's disease,continually developing peripheral patent technology,and thereby gaining greater market share and profits.
作者 吴永英 宋时雨 Wu Yongying;Song Shiyu(Patent Examination Cooperation Guangdong Center of the Patent Office,CNIPA,Guangzhou 510555,China)
出处 《广东化工》 CAS 2024年第15期98-100,共3页 Guangdong Chemical Industry
关键词 美金刚 专利 分析 Memantine patents analysis
作者简介 第一作者/通讯作者:吴永英(1988-),女,江西赣州人,助理研究员,硕士,主要研究方向为药物化学;第一作者:宋时雨(1987-),女,内蒙古锡林郭勒盟人,助理研究员,硕士,主要研究方向为药物化学。
  • 相关文献

参考文献3

二级参考文献24

  • 1李莎,崔慧先.雄激素防治阿尔茨海默病的研究现状[J].河北医科大学学报,2009,30(2):200-203. 被引量:4
  • 2Ohnishi T,Sakiyama Y,Okuri Y,et a1.The prediction of responseto galantamine treatment in patients with mild to moderate Alzheimer's disease[J].Curt Alzheimer Res,2014(11):110-118.
  • 3Zhang Z,Yu L,Gaudig M,et a1.Galantamine ve~us donepezil in Chinese patients with Alzheimer's disease:results from a randomized,double-blind study[J].Neuropsychiatr Dis Treat,2012(8):571-577.
  • 4Chen H S,Lipton S A.The chemical biology of clinically to1erated NMDA receptor antagonists[J].Journal of Neurochemistry,2006,97(6):l6l1-1626.
  • 5Schneider LS,Dagerman KS,Higgins JP,et a1.Lack of evidence for the efficacy of memantine in mild Alzheimer's disease[J].Arch Neurol,2011,68(8):991-998.
  • 6Kmietowicz Z.Patients with mild Alzheimer's disease should have access to drugs,says draft NICE guidance[J].BMJ,2010(341):c5562.
  • 7Ihl R,Bachinskaya N,Korczyn AD,et a1.Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features:a randomized controlled trial[J].Int J Geriatr Psychiatry,2011,26(11):1186-1194.
  • 8Birge SJ.Is there a role for estrogen replacement therapy in the prevention and treatment of dementia[J].J Am Geriatr Soc,1996,44(7):865-870.
  • 9Kanemaru K,Takio K,Miura R,et al.Feta1-type phosphorylation of the tau in paired helical filaments[J].J Neurochem,l992,58(5):l667-l675.
  • 10Wei Q,Holzer M,Brueckner MK,et al.Dephosphorylation of tau protein by calcineurin triturated into neural living cells[J].Cell Mol Neurobiol,2002,22(1):l3-24.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部